INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,372 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
KA
Kelly John AlexanderChief Financial Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
3,888 sh
Jan 20, 2026
Page 1470 of 1835
← PrevNext →
Jan 22, 2026
traded Jan 20, 2026
+2d
SEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Sheena JonathanDirector, CO-FOUNDER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
191 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
CL
Chapman Steven LeonardDirector, CEO AND PRESIDENT
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
3,386 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
14.9K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
37.1K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Option exercise · 10b5-1 plan
M—
13.6K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

62
BE
Brakewood Harold EugeneChief Business Officer
IMRXImmuneering Corp
Open-market purchase
BUY$25K
5,250 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

52
ML
Marantz Jing L.CHIEF MEDICAL OFFICER
SRRKScholar Rock Holding Corp
Open-market sale
SELL$258K
5,798 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

48
HJ
Ho JunlinGENERAL COUNSEL
SRRKScholar Rock Holding Corp
Open-market sale
SELL$357K
8,016 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

48
QM
Qatanani MoCHIEF SCIENTIFIC OFFICER
SRRKScholar Rock Holding Corp
Open-market sale
SELL$374K
8,406 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

48
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$15.09M
12.9K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

48
PC
Parlavecchio CarynCHRO
SRRKScholar Rock Holding Corp
Open-market sale
SELL$294K
6,600 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

45
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$9.54M
8,139 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

45
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$6.46M
5,514 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

36
AA
Attal AlainDirector
GMEGameStop Corp.
Open-market purchase
BUY$260K
12.0K sh
Jan 21, 2026Jan 21, 2026
traded Jan 21, 2026
+0dSEC Form 4

Evidence

35
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Option exercise
M$13.89M
27.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

34
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$590K
503 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

33
HC
Harmon CyrusDirector
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$269K
10.0K sh
Jan 20, 2026Jan 21, 2026
traded Jan 20, 2026
+1dSEC Form 4

Evidence

31
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,250 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC Form 4

Evidence

30
WT
Weitzel Gregory ThomasCFO
MATVMativ Holdings, Inc.
Disposition to issuer
D$113K
9,003 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

30
WJ
Wollin Robert JGENERAL COUNSEL AND SECRETARY
MGTXMeiraGTx Holdings plc
Tax withholding
F$202K
27.2K sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

30
EH
Exicure HiTron Inc.10% Owner
XCUREXICURE, INC.
Open-market sale
SELL$1.16M
258.4K sh
Jan 21, 2026Jan 21, 2026
traded Jan 21, 2026
+0dSEC Form 4

Evidence

29
SC
Selecky ChristobelDirector
IBRXImmunityBio, Inc.
Open-market sale · 10b5-1 plan
SELL$250K
50.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

27
FJ
Fleming Gregory JDirector
BLKBlackRock, Inc.
Grant or award
A—
214 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

27
WJ
Wollin Robert JGENERAL COUNSEL AND SECRETARY
MGTXMeiraGTx Holdings plc
Option exercise
M—
50.0K sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

27
WT
Weitzel Gregory ThomasCFO
MATVMativ Holdings, Inc.
Grant or award
A—
24.1K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

27
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
3,841 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

27
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
2,113 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

27
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

27
GW
Gerrity Robert WDirector, Chief Executive Officer
VTSVitesse Energy, Inc.
Open-market sale · 10b5-1 plan
SELL$610K
31.5K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

27
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

27
SA
Senn AndrewSVP, Strategy and Business Dev
ITGRInteger Holdings Corp
Option exercise
M—
630 sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

27
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$4.65M
120.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence